Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Syndax Pharmaceuticals, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Syndax Pharmaceuticals, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Syndax Pharmaceuticals, Inc..